Administration of macrolide antibiotics increases cardiovascular risk

Administration of macrolide antibiotics increases cardiovascular risk

BackgroundThe increased risk of cardiovascular events in patients prescribed macrolides has been subject to debate for decades.MethodsMedline, EMBASE databases and ClinicalTrials.gov were searched from inception until August 31, 2022 for studies investigating the link between macrolides and cardiova...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Yang Wu, Wen-Tao Bi, Li-Ping Qu, Jun Fan, Xiang-Jun Kong, Cheng-Cheng Ji, Xu-Miao Chen, Feng-Juan Yao, Li-Juan Liu, Yun-Jiu Cheng, Su-Hua Wu
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Frontiers Media S.A. 2023-02-01
Sarja:Frontiers in Cardiovascular Medicine
Aiheet:
sudden cardiac death
macrolide antibiotics
cardiovascular risk
meta-analysis
ventricular arrhythmia
Linkit:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1117254/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1117254/full

Samankaltaisia teoksia